Endometriumveränderungen nach Tamoxifen-Therapie-Reference-Cited by-同舟云学术

Endometriumveränderungen nach Tamoxifen-Therapie

Published:2006-02 Issue:1 Volume:27 Page:27-32
ISSN:0172-8113
Container-title:Der Pathologe
language:de
Short-container-title:Pathologe

Author:

Schmidt D.

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00292-005-0808-8.pdf

Reference19 articles.

1. Barakat RR, Gilewski TA, Almadrones L et al. (2000) Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol 18:3459–3463

2. Bergman L, Beelen ML, Gallee MP et al. (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres‘ ALERT Group (Assessment of Liver and Endometrial cancer Risk following Tamoxifen). Lancet 356:881–887

3. Berliere M, Charles A, Galant C, Donnez J (1998) Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 91:40–44

4. Burckhardt P (1999) Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy. Schweiz Med Wochenschr 129:1926–1930

5. Cohen I (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94:256–266

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sonographic Changes in Endometrium after Use of Tamoxifen in Breast Cancer;Pakistan Journal of Health Sciences;2023-08-31

2. Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?;Journal of Obstetrics and Gynaecology;2022-12-28

3. RAD001 (Everolimus) Can Prevent Tamoxifen-Related Endometrial and Stromal Hyperplasia;International Journal of Gynecologic Cancer;2009-03

4. Diagnostic accuracy of sonohysterography in the evaluation of uterine cavities in tamoxifen administered asymptomatic postmenopausal breast cancer patients with endometrial thickness ≥5 mm;Gynecological Surgery;2006-09-07

5. Current awareness: Pharmacoepidemiology and drug safety;Pharmacoepidemiology and Drug Safety;2006